Asia Pacific Biosimilars Market Analysis: China vs S.Korea (2024–2032)

Free

in USD Million

China to Lead the Asia Pacific Biosimilars Market Growth, with South Korea as the Innovation Hub

Published by MMR Statistics Reserch Team, November 2025

China and South Korea continued to shape the competitive landscape of the Asia Pacific Biosimilars Market, with both countries demonstrating strong upward momentum through 2032. China was valued at USD 1,621.45 million in 2024 and is projected to increase to USD 5,136.21 million by 2032, supported by large-scale manufacturing capacity, expanding regulatory approvals, and strong domestic demand across oncology and autoimmune therapies. South Korea, a global biosimilars innovation hub, was valued at USD 869.87 million in 2024 and is projected to reach USD 2,300.09 million by 2032, driven by its advanced R&D ecosystem, leading biopharma manufacturers, and a progressive export-oriented pipeline.

OTHER STATISTICS ON TOPIC

Biosimilars

More statistics on Biosimilars

Download

Information

Unit

in USD Million

Region

Asia-Pacific (APAC)

Time Period

2024-2032

Source Name

Maximize Market Research Pvt. Ltd

Source Link

http://www.maximizemarketresearch.com

Publisher Name

Maximize Market Research Pvt. Ltd

Publisher Link

http://www.maximizemarketresearch.com

Related reports

Market Research Reports on Biosimilars

Explore published research tied to this statistic's topic. Open the featured edition or jump into another region without leaving the page.

Open featured report

Subscriptions

Stay ahead of Biosimilars with tailored access

Sample free-tier statistics or unlock premium coverage for this topic with team-friendly usage rights.

Discover

Try free-tier statistics before committing to a plan.

Start for Free

Professional

Unlock premium coverage across this topic with analyst support.

Select Plan

Contact our team

Need a bespoke deep-dive on Biosimilars?

Tell us about your KPIs and coverage priorities. We can tailor a briefing, share methodology notes, or build a custom dataset that complements the reports and statistics you are browsing.

Talk with an analyst